The Federal Circuit held that patent owners may amend claims during inter partes review to address issues beyond the specific grounds raised in the petition, provided the amendments do not enlarge claim scope or add new matter.
The Federal Circuit held that although an irrevocable patent license cannot be unilaterally revoked by the grantor, both parties may mutually agree to terminate it, and doing so restores the licensor’s standing to bring patent infringement suits against the former licensee.
The Federal Circuit reversed a district court’s ruling that the claim term “Downloadable” was indefinite in Finjan’s computer virus detection patents, holding that the term’s plain meaning — an executable or interpretable application program — was sufficiently definite.
The Federal Circuit issued two precedential opinions vacating preliminary injunctions in hoverboard design patent cases, holding that courts must conduct product-by-product infringement analysis under the ordinary observer test and properly account for prior art when evaluating likelihood of success
The Federal Circuit reversed an indefiniteness ruling against patents covering geometric meshing methods used in computer-aided design, holding that the district court applied an incorrect ‘unanswered questions’ test rather than the proper ‘reasonable certainty’ standard from
The Federal Circuit affirmed that IBM’s patents covering coordinated map-based and list-based selection of geographic data were directed to the abstract idea of organizing and displaying visual information, lacking an inventive concept sufficient for patent eligibility.
The Federal Circuit addressed trade secret and copyright claims arising from TA Instruments’ alleged misappropriation of Malvern Panalytical’s confidential algorithms and software for rheology instruments — affirming the district court’s rulings on preemption of state trade secret
The Federal Circuit reversed dismissal of a peer-to-peer video delivery network patent under § 101, holding that the complaint plausibly alleged the claims represented a specific technical improvement over prior content distribution networks.
The Federal Circuit affirmed infringement of Corcept Therapeutics’ method-of-treatment patents covering combination therapy using mifepristone with a strong CYP3A inhibitor — finding that Teva’s ANDA label induced infringement and rejecting Teva’s challenge to the skinny label carv
The Federal Circuit affirmed rejection of claims covering a computer-implemented system for identifying Social Security Disability Insurance eligibility, holding the claims were directed to an abstract mental process that humans perform through observation and evaluation.